PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.15%
Revenue growth under 50% of ANO.AX's 62.13%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
27.22%
Gross profit growth under 50% of ANO.AX's 251.94%. Michael Burry would be concerned about a severe competitive disadvantage.
334.31%
EBIT growth above 1.5x ANO.AX's 155.25%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
334.31%
Operating income growth at 50-75% of ANO.AX's 648.74%. Martin Whitman would doubt the firm’s ability to compete efficiently.
2587.67%
Net income growth above 1.5x ANO.AX's 161.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-35.50%
Share reduction while ANO.AX is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-18.95%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-76.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-78.87%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-73.52%
Negative 10Y revenue/share CAGR while ANO.AX stands at 223.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-53.52%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
8.11%
3Y revenue/share CAGR 1.25-1.5x ANO.AX's 6.96%. Bruce Berkowitz might see better product or regional expansions than the competitor.
112.96%
10Y OCF/share CAGR 1.25-1.5x ANO.AX's 77.99%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
374.44%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
298.40%
3Y OCF/share CAGR under 50% of ANO.AX's 878.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
124.44%
Below 50% of ANO.AX's 4293.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
130.79%
Positive 5Y CAGR while ANO.AX is negative. John Neff might view this as a strong mid-term relative advantage.
183.33%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4378.96%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
165.91%
AR growth well above ANO.AX's 53.52%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
We show growth while ANO.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
12.43%
Asset growth above 1.5x ANO.AX's 3.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
116.00%
BV/share growth above 1.5x ANO.AX's 2.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-45.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-50.01%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
6.62%
SG&A declining or stable vs. ANO.AX's 14.86%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.